BiotechTube
Home/PMV Pharmaceuticals/Kathleen Mahoney, M.D.
KM

Kathleen Mahoney, M.D.

Chief Medical Officer

PMV Pharmaceuticals

Therapeutic Areas

OncologyPrecision Medicine

PMV Pharmaceuticals Pipeline

DrugIndicationPhase
PC14586 (revetrectinib)Advanced solid tumors with p53 Y220C mutationPhase 1/2

Leadership Team at PMV Pharmaceuticals

DM
David Mack, Ph.D.
Co-founder, President and Chief Executive Officer
DJ
Deepika Jalota
Chief Business Officer
WK
Winston Kung
Chief Financial Officer
AL
Arnold Levine, Ph.D.
Co-founder and Chair of Scientific Advisory Board
AG
Andreas G. Bader, Ph.D.
Chief Scientific Officer
CP
Carol Prives, Ph.D.
Scientific Advisory Board Member
AF
Alan Fersht, Ph.D.
Scientific Advisory Board Member
View full PMV Pharmaceuticals profile